PHS
NVRO
PFM Health Sciences’s NEVRO CORP. NVRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-563,560
| Closed | -$26.3M | – | 89 |
|
|
2022
Q3 | $26.3M | Sell |
563,560
-95,850
| -15% | -$4.47M | 0.95% | 45 |
|
|
2022
Q2 | $28.9M | Buy |
659,410
+9,897
| +2% | +$434K | 1.1% | 40 |
|
|
2022
Q1 | $47M | Buy |
649,513
+164,378
| +34% | +$11.9M | 1.76% | 21 |
|
|
2021
Q4 | $39.3M | Buy |
485,135
+92,349
| +24% | +$7.49M | 1.34% | 38 |
|
|
2021
Q3 | $45.7M | Sell |
392,786
-25,859
| -6% | -$3.01M | 1.34% | 29 |
|
|
2021
Q2 | $69.4M | Sell |
418,645
-26,232
| -6% | -$4.35M | 2.18% | 15 |
|
|
2021
Q1 | $62.1M | Buy |
444,877
+132,937
| +43% | +$18.5M | 1.9% | 15 |
|
|
2020
Q4 | $54M | Sell |
311,940
-6,292
| -2% | -$1.09M | 1.9% | 14 |
|
|
2020
Q3 | $44.3M | Buy |
318,232
+214,052
| +205% | +$29.8M | 2.05% | 11 |
|
|
2020
Q2 | $12.4M | Buy |
+104,180
| New | +$12.4M | 0.65% | 45 |
|
|
2020
Q1 | – | Sell |
-577,163
| Closed | -$67.8M | – | 75 |
|
|
2019
Q4 | $67.8M | Buy |
577,163
+180,893
| +46% | +$21.3M | 3.23% | 5 |
|
|
2019
Q3 | $34.1M | Sell |
396,270
-434,564
| -52% | -$37.4M | 1.01% | 37 |
|
|
2019
Q2 | $53.9M | Buy |
830,834
+109,605
| +15% | +$7.11M | 1.02% | 31 |
|
|
2019
Q1 | $45.1M | Buy |
721,229
+165,134
| +30% | +$10.3M | 1% | 30 |
|
|
2018
Q4 | $21.6M | Buy |
+556,095
| New | +$21.6M | 0.57% | 53 |
|
|
2017
Q2 | – | Sell |
-116,836
| Closed | -$10.9M | – | 112 |
|
|
2017
Q1 | $10.9M | Buy |
+116,836
| New | +$10.9M | 0.27% | 78 |
|